Pluri Inc. — Director's Dealing 2020

Sep 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2020-09-10

Reporting Person: YANAY YAKY (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-10	Restricted Stock Units	A	500000	—	Acquired	925304	Direct
2020-09-10	Restricted Stock Units	A	500000	—	Acquired	1425304	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6650	Indirect

Footnotes

F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.

F3: The shares vest in full upon milestone achievement of increasing market capitalization of the Issuer's common stock on the Nasdaq Capital Market to $550 million within no more than 3 years from the date of grant.

F4: Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019.